Sumitomo Chemical India Limited has informed the Exchange regarding Board meeting held on August 04, 2025.

Revenue Growth 20pctPat Growth 25pctResults View source PDF Explain this filing

SUMICHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.3%Reaction day

₹629.95

prior close

₹638.70

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+1.0%+0.3% vs market

Pesticides & Agrochemicals peers, median of 25sector+0.6%+0.8% vs sector

On the reaction day the stock moved 0.3 pts more than Nifty Smallcap 250 and 0.8 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.2

10m

+1.2

15m

+0.2

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.3+1.0+0.3+0.6+0.8

Next day

+0.1+0.7-0.5-0.8+1.0

-4.3-0.6-3.7-2.1-2.2

-6.5-0.7-5.8-2.8-3.7

-8.7-1.9-6.8-5.9-2.9

-7.4-1.5-5.9-5.7-1.7

-5.4-0.8-4.6-7.0+1.6

15d

-10.3-0.7-9.6-7.5-2.8

-7.6+0.0-7.6-8.3+0.7

-14.3+1.0-15.3-12.6-1.7

-20.7+2.7-23.4-19.2-1.5

UpDownMarket · Nifty Smallcap 250Sector · Pesticides & Agrochemicals peers, median of 25Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sumitomo Chemical India reported strong Q1 FY26 results with standalone revenue from operations rising to ₹10,480.69 million, up about 26% from ₹8,317.84 million in the same quarter last year. Standalone profit after tax jumped to ₹1,798.06 million from ₹1,283.91 million, a growth of roughly 40% year-on-year. Consolidated results were equally robust, with revenue at ₹10,567.79 million and PAT at ₹1,780.96 million, also up around 40% YoY. Standalone EPS stood at ₹3.60 (not annualised) versus ₹2.57 in Q1 FY25. The auditors (BSR & Co. LLP) issued an unmodified limited review opinion on both standalone and consolidated results.

Likely market impact

Strong double-digit growth in both revenue and profits signals robust business momentum and is likely to be viewed positively by shareholders. The result reinforces confidence in the company's agro-chemicals segment performance heading into the key kharif season.